Form 4 for FLGT Fulgent Genetics, Inc.
Accepted 2025-11-21 00:00:00 ET · period of report 2025-11-19 · accession 0001193125-25-291451 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-21 | 2025-11-19 | FLGT | Xie Jian | Pres, COO | G - Gift | $0.00 | -10.0K | 339.8K | -3% | $0 | |
| 2025-11-21 | 2025-11-19 | FLGT | Xie Jian | Pres, COO | S - Sale | $29.10 | -10.0K | 349.8K | -3% | -$291.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-19 | G | D | 10,000 | $0.00 | 339,768 | D | — | — | (F3) Reflects shares transferred as a gift to the James and Karena Xie Family Foundation (the "Foundation"), of which, the reporting person is the president and has voting and investment power over all securities owned by the foundation. |
| 2 | Common | Common Stock | 2025-11-19 | S | D | 10,000 | $29.10 | 349,768 | D | — | — | (F1) The shares were sold by the reporting person for year-end tax planning. (F2) The shares were sold in multiple transactions at prices ranging from $29.07 to $29.1985, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |